Taylor Frigon Capital Management LLC Has $2.61 Million Stake in Astera Labs, Inc. $ALAB

Taylor Frigon Capital Management LLC decreased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 8.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 23,789 shares of the company’s stock after selling 2,278 shares during the quarter. Astera Labs comprises about 1.5% of Taylor Frigon Capital Management LLC’s investment portfolio, making the stock its 10th largest holding. Taylor Frigon Capital Management LLC’s holdings in Astera Labs were worth $2,607,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ALAB. Swedbank AB boosted its stake in Astera Labs by 16.5% during the 1st quarter. Swedbank AB now owns 91,020 shares of the company’s stock valued at $9,976,000 after purchasing an additional 12,880 shares during the period. Clay Northam Wealth Management LLC grew its holdings in Astera Labs by 9.2% in the 1st quarter. Clay Northam Wealth Management LLC now owns 4,203 shares of the company’s stock worth $461,000 after buying an additional 355 shares in the last quarter. Westfuller Advisors LLC acquired a new stake in Astera Labs in the 1st quarter valued at approximately $73,000. Stephens Inc. AR boosted its position in Astera Labs by 26.2% during the 1st quarter. Stephens Inc. AR now owns 2,867 shares of the company’s stock worth $314,000 after acquiring an additional 596 shares during the period. Finally, Stephens Investment Management Group LLC grew its stake in shares of Astera Labs by 13.0% in the first quarter. Stephens Investment Management Group LLC now owns 269,885 shares of the company’s stock worth $29,579,000 after purchasing an additional 31,108 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. TD Cowen upped their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Bank of America increased their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. UBS Group boosted their target price on Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a report on Monday, June 29th. Roth Capital reaffirmed a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, Needham & Company LLC boosted their price objective on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $265.75.

Insider Activity at Astera Labs

In related news, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,164,441 shares of company stock worth $526,198,280 in the last quarter. 10.40% of the stock is owned by company insiders.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $393.16 on Thursday. The stock has a market capitalization of $67.39 billion, a price-to-earnings ratio of 265.65, a PEG ratio of 4.39 and a beta of 3.66. Astera Labs, Inc. has a 1-year low of $88.18 and a 1-year high of $499.48. The company has a 50 day moving average price of $326.75 and a 200 day moving average price of $211.47.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.